Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04002882 · ClinicalTrials.gov registry record

Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)

A clinical trial of Cystic Fibrosis, sponsored by Emory University.

Recruiting
Registry status
90
Enrollment target
2
Study locations

NCT04002882 is a study of Cystic Fibrosis that is actively recruiting participants, run by Emory University. The registered enrollment target is 90 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (50% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04002882, a study of Cystic Fibrosis, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
90 participants
Enrollment target
2
Study locations

Study Summary

Nutrition and body composition, the amount of muscle and fat in the body, has a role in overall health. This study wants to learn more about how nutrition and body composition affects health outcomes like glucose tolerance and lung function in patients with cystic fibrosis (CF) who are ages 16-30 years old. 60 adolescents and young adults with CF will be recruited, and 30 volunteers without cystic fibrosis. A total of 40 of these study participants with CF will be asked to return for annual study visits for 2 years after the first visit. The long-term goal of this study is to use the information collected to make decisions about future nutrition monitoring and interventions which help maintain optimal health for individuals with CF.

Conditions Studied

Study Locations (2)

Alabama

  • University of Alabama at Birmingham (UAB)/Children's of Alabama - Birmingham

Georgia

  • Emory University/Children's Hospital of Atlanta (CHOA) - Atlanta

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-07-08
Est. Completion 2026-05

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04002882

The ClinicalTrials.gov registry entry for NCT04002882 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (50% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.

NCT04002882 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Georgia.

Frequently Asked Questions

What is clinical trial NCT04002882 about?

NCT04002882 is a clinical study titled "Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)". Nutrition and body composition, the amount of muscle and fat in the body, has a role in overall health. This study wants to learn more about how nutrition and body composition affects health outcomes like glucose tolerance and lung function in patients with cystic fibrosis (CF) who are ages 16-30 ye...

What is the current status of trial NCT04002882?

This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2019-07-08. Estimated completion is 2026-05.

What conditions does trial NCT04002882 study?

This clinical trial studies the following conditions: Cystic Fibrosis.

Who is sponsoring clinical trial NCT04002882?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04002882 being conducted?

This trial has 2 study locations across Alabama, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.